Literature DB >> 18566039

Principal component analysis of CYP2C9 and CYP3A4 probe substrate/inhibitor panels.

Abhinav Nath1, William Atkins.   

Abstract

Cytochrome P450 (P450) inhibition often occurs in a strongly substrate- and inhibitor-dependent manner, with a given inhibitor affecting the metabolism of different substrates to differing degrees and with a given substrate responding differently to different inhibitors. Traditionally, patterns of functional similarity and dissimilarity among substrates and inhibitors have been studied using clustering analysis of pair-wise correlation coefficients. Principal component analysis (PCA) is a widely used statistical technique that identifies the globally most significant independent trends in a set of data. Here, we show that PCA can be usefully applied to study the differential effects on a panel of P450 probe substrates by a panel of inhibitors, using published data on CYP3A4 (Kenworthy et al., 1999) and CYP2C9 (Kumar et al., 2006). PCA can detect functional similarities among substrates and inhibitors that are not readily apparent using pair-wise clustering analysis. PCA also allows identification of the functionally typical and atypical substrates that might be used in combination to fully explore the P450 functional landscape.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566039      PMCID: PMC2577166          DOI: 10.1124/dmd.108.022061

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  CYP3A4 drug interactions: correlation of 10 in vitro probe substrates.

Authors:  K E Kenworthy; J C Bloomer; S E Clarke; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles.

Authors:  Vikas Kumar; Jan L Wahlstrom; Dan A Rock; Chad J Warren; Lee A Gorman; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2006-09-08       Impact factor: 3.922

Review 3.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

Authors:  F P Guengerich
Journal:  Chem Res Toxicol       Date:  2001-06       Impact factor: 3.739

Review 4.  Current views on the fundamental mechanisms of cytochrome P450 allosterism.

Authors:  William M Atkins
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-08       Impact factor: 4.481

5.  CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles.

Authors:  Robert S Foti; Jan L Wahlstrom
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

6.  A quantitative index of substrate promiscuity.

Authors:  Abhinav Nath; William M Atkins
Journal:  Biochemistry       Date:  2007-12-15       Impact factor: 3.162

7.  Neutral genetic drift can alter promiscuous protein functions, potentially aiding functional evolution.

Authors:  Jesse D Bloom; Philip A Romero; Zhongyi Lu; Frances H Arnold
Journal:  Biol Direct       Date:  2007-06-28       Impact factor: 4.540

  7 in total
  3 in total

1.  Quantifying and predicting the promiscuity and isoform specificity of small-molecule cytochrome P450 inhibitors.

Authors:  Abhinav Nath; Michael A Zientek; Benjamin J Burke; Ying Jiang; William M Atkins
Journal:  Drug Metab Dispos       Date:  2010-09-14       Impact factor: 3.922

2.  CW EPR parameters reveal cytochrome P450 ligand binding modes.

Authors:  Molly M Lockart; Carlo A Rodriguez; William M Atkins; Michael K Bowman
Journal:  J Inorg Biochem       Date:  2018-02-24       Impact factor: 4.155

3.  Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries.

Authors:  Henrike Veith; Noel Southall; Ruili Huang; Tim James; Darren Fayne; Natalia Artemenko; Min Shen; James Inglese; Christopher P Austin; David G Lloyd; Douglas S Auld
Journal:  Nat Biotechnol       Date:  2009-10-25       Impact factor: 54.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.